@article{361cd912ebbd4d1b9c921c179221b222,
title = "Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial",
abstract = "Dianicline is a α4β2 nicotinic acetylcholine receptor partial agonist, a class of drugs that includes varenicline and cytisine. Varenicline is efficacious for smoking cessation, while cytisine has not been studied systematically. The efficacy of dianicline has not been previously tested in an adequately powered study.",
keywords = "Adult, Azepines, Double-Blind Method, Female, Heterocyclic Compounds with 4 or More Rings, Humans, Male, Middle Aged, Nicotinic Agonists, Placebos, Receptors, Nicotinic, Smoking, Smoking Cessation",
author = "Serena Tonstad and Ingar Holme and Philip T{\o}nnesen",
year = "2011",
month = jan,
day = "1",
doi = "10.1093/ntr/ntq191",
language = "English",
volume = "13",
pages = "1--6",
journal = "Nicotine & Tobacco Research",
issn = "1462-2203",
publisher = "Oxford University Press",
number = "1",
}